Skip to Main Content


Kelly Olino, MD, FACS

Assistant Professor of Surgery (Oncology); Leader, Skin Cancer Surgery, Melanoma Program; Clinical Director of the Smilow Melanoma Program, Yale Cancer Center



Kelly Olino, MD, FACS, Assistant Professor of Surgical Oncology, is a doubly board certified surgeon who provides patients with comprehensive surgical care including resection of skin and soft tissue tumors including melanoma, merkel cell carcinoma, sarcoma and advanced cutaneous squamous cell and basal cell carcinoma, including minimally invasive techniques for metastatic disease.

Learn more about Dr. Olino>>

Dr. Olino joined the Yale School of Medicine from the University of Texas Medical Branch in Galveston, Texas, where she was recognized as a Texas Rising Star. She is board certified in Complex Surgical Oncology and General Surgery. While in Texas she was recognized for her melanoma research as a Provost Scholar and a recipient of the Society for Surgical Oncology’s Clinical Investigator Award to support her research in tumor immunology. She continued this work at Yale as a Calabresi Immune-Oncology scholar combining her knowledge of tumor immunology with her clinical acumen. She has served on national committees for the management of melanoma and currently serves on the NCCN non-melanoma cutaneous malignancy committee.

She completed her surgical residency at The Johns Hopkins School of Medicine and a fellowship in complex surgical oncology at the Memorial Sloan Kettering Cancer Center. Dr. Olino cares for patients at the Smilow Cancer Hospital at Yale New Haven and Guilford, along with strong multi-disciplinary disease specific teams. She looks forward to partnering with colleagues in the community and providing her expertise to patients.

Education & Training

  • Fellowship
    The Memorial Sloan Kettering Cancer Center (2015)
  • Residency
    The Johns Hopkins Hospital (2013)
  • MD
    The Johns Hopkins School of Medicine (2005)
  • BS
    Cornell University, Biological Sciences-Neurobiology (2000)


  • What's Next? Treatment Choices After Anti-PD-1 Antibody
    Chicago, IL, United States 2022
    2022 ASCO Annual Meeting
  • Merkel Cell Carcinoma: Tumor Biology and Biomarkers.
    Dallas, TX, United States 2022
    Society of Surgical Oncology 2022 International Conference on Surgical Cancer Care
  • The Changing Landscape for Merkel Cell Carcinoma
    Virtual due to COVID-19 2022
    The Johns Hopkins Department of Surgery Grand Rounds
  • The Evolution in the Management of Merkel Cell Carcinoma at Yale: Past Experience and Future Directions
    New Haven, CT. Virtual due to COVID-19 2022
    Yale Cancer Center Grand Rounds
  • Surgical Oncology Potpourri for the ABSITE
    Virtual due to COVID-19 2022
    Connecticut Chapter of the American College of Surgeons
  • Co-targeting the innate and adaptive immune systems to overcome resistance to anti-PD(L)-1
    Virtual due to COVID-19 2021
    Inter-SPORE Melanoma Meeting

Honors & Recognition

AwardAwarding OrganizationDate
Texas Rising StarsSuper Doctors2018
Golden Scalpel Medical Student Teaching AwardUniversity of Texas Medical Branch School of Medicine2016
Society for Surgical Oncology Clinical Investigators Award Society for Surgical Oncology Foundation2016
Frank Coulson Resident Clinical Excellence AwardThe Johns Hopkins School of Medicine2013
Department of Surgery Medical Student Teaching AwardThe Johns Hopkins School of Medicine2013
Anthony Imbembo Resident Teaching AwardThe Johns Hopkins School of Medicine2013
Anthony Imbembo Resident Teaching AwardThe Johns Hopkins School of Medicine2012
Anthony Imbembo Resident Teaching AwardThe Johns Hopkins School of Medicine2011
Baltimore Academy of Surgery Research Award2009
George Zuidema Basic Science AwardThe Johns Hopkins School of Medicine2008

Professional Service

The Society of Surgical OncologyScientific Program Committee- Chair Immuno-oncology subgroup2022 - Present
Status of Women in Medicine- Department of Surgery LiasonLiaison2022 - Present
National Comprehensive Cancer Network- Non-Melanoma Skin Cancer Guideline PanelCreation of national guidelines for merkel cell carcinoma, cutaneous squamous cell carcinoma, basal cell carcinoma and dermatofibrosarcoma protuberans2022 - Present
Yale New Haven Hospital Credentials CommitteeMember2021 - Present
Yale Cancer Center - Smilow Clinical CouncilMember2021 - Present
Schwartz Cancer Center Grand Rounds Planning CommitteeCommittee Member2021 - Present
The Society of Surgical OncologyMelanoma Disease Site Working Group. Planning of education activities and guidelines for the management of cutaneous malignancies.2020 - 2022
Yale Center for Immuno-OncologySymposia and seminar planning committee2019 - Present
Association for Academic SurgeryProgram Committee2016 - Present

Departments & Organizations